Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends

On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006–2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85%) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3%) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90% since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including haploidentical family donors. These findings contrast with the prevalence of autologous over allogeneic HSCT, and a higher frequency of unrelated HSCT in other parts of the world. Of note, the increase by 200% in HSCT for hemoglobinopathies from 2006 to 2013 (72 per year) in the AFR/EMRO region. This reflects the specific role of HSCT for these disease categories with high prevalence and incidence in the AFR/EMRO region. This report provides information for the competent authorities to foster adequate infrastructure. It urges transplant organization to optimize their cooperation.

Original languageEnglish (US)
Pages (from-to)402-417
Number of pages16
JournalBone marrow transplantation
Volume54
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Mediterranean Region
Hematopoietic Stem Cell Transplantation
Transplants
Hemoglobinopathies
Organizations

PubMed: MeSH publication types

  • Journal Article

Cite this

On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT) (2019). Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. Bone marrow transplantation, 54(3), 402-417. https://doi.org/10.1038/s41409-018-0275-5

Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region : comparison with global HSCT indications and trends. / On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT).

In: Bone marrow transplantation, Vol. 54, No. 3, 01.03.2019, p. 402-417.

Research output: Contribution to journalArticle

On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT) 2019, 'Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends', Bone marrow transplantation, vol. 54, no. 3, pp. 402-417. https://doi.org/10.1038/s41409-018-0275-5
On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT). Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. Bone marrow transplantation. 2019 Mar 1;54(3):402-417. https://doi.org/10.1038/s41409-018-0275-5
On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT). / Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region : comparison with global HSCT indications and trends. In: Bone marrow transplantation. 2019 ; Vol. 54, No. 3. pp. 402-417.
@article{6aaf90f7c6ef4b01bdf79f2b3a04b473,
title = "Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends",
abstract = "Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006–2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85{\%}) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3{\%}) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90{\%} since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including haploidentical family donors. These findings contrast with the prevalence of autologous over allogeneic HSCT, and a higher frequency of unrelated HSCT in other parts of the world. Of note, the increase by 200{\%} in HSCT for hemoglobinopathies from 2006 to 2013 (72 per year) in the AFR/EMRO region. This reflects the specific role of HSCT for these disease categories with high prevalence and incidence in the AFR/EMRO region. This report provides information for the competent authorities to foster adequate infrastructure. It urges transplant organization to optimize their cooperation.",
author = "{On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)} and Helen Baldomero and Mahmoud Aljurf and Zaidi, {Syed Z.A.} and Hashmi, {Shahrukh K.} and Ardeshir Ghavamzadeh and Alaa Elhaddad and Hamladji, {Rose Marie} and Parvez Ahmed and Lamia Torjemane and Miguel Abboud and Abdelghani Tbakhi and Khabori, {Murtadha Al} and {El Quessar}, Asma and Nosa Bazuaye and Bekadja, {Mohamed Amine} and Salman Adil and Omar Fahmy and Mani Ramzi and Ahmed Ibrahim and Amal Alseraihy and {Ben Abdejalil}, Nour and Mahmoud Sarhan and Huneini, {Mohammed Al} and Lahoucine Mahmal and Hassan ElSolh and Fazal Hussain and Amr Nassar and Hani Al-Hashmi and Hamidieh, {Amir Ali} and Marcelo Pasquini and Yoshihisa Kodera and Nicolaus Kr{\"o}ger and Mohamed Mohty and Gregorio Jaimovich and Rolon, {Juliana Martinez} and Kristjan Paulson and Hildegard Greinix and Weisdorf, {Daniel J} and Mary Horowitz and Jos{\'e} Nunez and Alois Gratwohl and Jacob Passweg and Mickey Koh and Jeff Szer and Dietger Niederwieser and Nicolas Novitzky",
year = "2019",
month = "3",
day = "1",
doi = "10.1038/s41409-018-0275-5",
language = "English (US)",
volume = "54",
pages = "402--417",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region

T2 - comparison with global HSCT indications and trends

AU - On behalf of the East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)

AU - Baldomero, Helen

AU - Aljurf, Mahmoud

AU - Zaidi, Syed Z.A.

AU - Hashmi, Shahrukh K.

AU - Ghavamzadeh, Ardeshir

AU - Elhaddad, Alaa

AU - Hamladji, Rose Marie

AU - Ahmed, Parvez

AU - Torjemane, Lamia

AU - Abboud, Miguel

AU - Tbakhi, Abdelghani

AU - Khabori, Murtadha Al

AU - El Quessar, Asma

AU - Bazuaye, Nosa

AU - Bekadja, Mohamed Amine

AU - Adil, Salman

AU - Fahmy, Omar

AU - Ramzi, Mani

AU - Ibrahim, Ahmed

AU - Alseraihy, Amal

AU - Ben Abdejalil, Nour

AU - Sarhan, Mahmoud

AU - Huneini, Mohammed Al

AU - Mahmal, Lahoucine

AU - ElSolh, Hassan

AU - Hussain, Fazal

AU - Nassar, Amr

AU - Al-Hashmi, Hani

AU - Hamidieh, Amir Ali

AU - Pasquini, Marcelo

AU - Kodera, Yoshihisa

AU - Kröger, Nicolaus

AU - Mohty, Mohamed

AU - Jaimovich, Gregorio

AU - Rolon, Juliana Martinez

AU - Paulson, Kristjan

AU - Greinix, Hildegard

AU - Weisdorf, Daniel J

AU - Horowitz, Mary

AU - Nunez, José

AU - Gratwohl, Alois

AU - Passweg, Jacob

AU - Koh, Mickey

AU - Szer, Jeff

AU - Niederwieser, Dietger

AU - Novitzky, Nicolas

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006–2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85%) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3%) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90% since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including haploidentical family donors. These findings contrast with the prevalence of autologous over allogeneic HSCT, and a higher frequency of unrelated HSCT in other parts of the world. Of note, the increase by 200% in HSCT for hemoglobinopathies from 2006 to 2013 (72 per year) in the AFR/EMRO region. This reflects the specific role of HSCT for these disease categories with high prevalence and incidence in the AFR/EMRO region. This report provides information for the competent authorities to foster adequate infrastructure. It urges transplant organization to optimize their cooperation.

AB - Hematopoietic Stem Cell Transplantation (HSCT) activity was evaluated in the African (AFR)/EMRO region and compared to the global activity for the years 2006–2013. Data were obtained from 1570 teams in the 6 WHO continental regions. Of these, 29 (1.85%) of all teams were active in 12 of the 68 AFR/EMRO countries. They reported 2.331 (3.3%) of the worldwide 71.036 HSCT, and a transplant rate of 32.8 (TR; HSCT/10 million inhabitants; worldwide 128.5). This reflects still the lowest regional TR despite an increase of 90% since 2006. HSCT activity in AFR/EMRO countries was characterized by a higher use of allogeneic compared to autologous HSCT, an almost exclusive use of family donors, including haploidentical family donors. These findings contrast with the prevalence of autologous over allogeneic HSCT, and a higher frequency of unrelated HSCT in other parts of the world. Of note, the increase by 200% in HSCT for hemoglobinopathies from 2006 to 2013 (72 per year) in the AFR/EMRO region. This reflects the specific role of HSCT for these disease categories with high prevalence and incidence in the AFR/EMRO region. This report provides information for the competent authorities to foster adequate infrastructure. It urges transplant organization to optimize their cooperation.

UR - http://www.scopus.com/inward/record.url?scp=85052538993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052538993&partnerID=8YFLogxK

U2 - 10.1038/s41409-018-0275-5

DO - 10.1038/s41409-018-0275-5

M3 - Article

C2 - 30082852

AN - SCOPUS:85052538993

VL - 54

SP - 402

EP - 417

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 3

ER -